Lombard Odier Asset Management (Usa) Corp Vertex Pharmaceuticals Inc Transaction History

Lombard Odier Asset Management (Usa) Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $7.38 Million - $9.32 Million	-41,690 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $6.09 Million - $6.82 Million	33,596 Added 415.07%	41,690 $7.56 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $1.52 Million - $1.79 Million	8,094 New	8,094 $1.63 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $1.92 Million - $2.27 Million	-7,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $947,016 - $1.24 Million	-4,200 Reduced 35.9%	7,500 $2.18 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $2.34 Million - $2.9 Million	11,700 New	11,700 $2.78 Million

1,725

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.